Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0708_scitranslmed.aaz5683

Promoting expression of immune targets IFI16 and NLRC5 for melanoma

Aug 27, 2020 | 9:34 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Melanoma

Promoting the expression of immune genes IFI16 and

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE